Literature DB >> 3535354

Pathogenesis of multiple sclerosis. A critical reappraisal.

C M Poser.   

Abstract

The pathogenesis of multiple sclerosis remains a dilemma despite many years of study. Evidence for an infective agent is lacking: much doubt remains regarding the pathogenetic significance, if any, of the many reported alterations of the immune system. On the other hand, the well-documented facts that multiple sclerosis plaques are invariably located around blood vessels and that alterations of the blood-brain barrier permeability are always present in the plaque suggest that these old observations should be reconsidered. There is strong evidence to support the idea that the alteration of the blood-brain barrier is an obligatory step in the development of the plaque. It may result from a variety of environmental factors among which must be mentioned trauma to the nervous system, as well as the immunological changes resulting from viral infections and vaccinations. The available data lead to the following hypothesis: multiple sclerosis is a disease which requires the following factors for the production of demyelinating lesions of the central nervous system: a genetically determined susceptibility, an environmental, probably viral, probably immune-mediated initiatory event producing a symptomless systemic illness, a subsequent alteration of the blood-brain barrier resulting from diverse mechanisms including trauma or a second, immune-mediated event, a myelinoclastic plaque-forming mechanism which is operative only in the central nervous system.

Entities:  

Mesh:

Year:  1986        PMID: 3535354     DOI: 10.1007/BF00687954

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  66 in total

1.  INFECTION AND IMMUNIZATION IN MULTIPLE SCLEROSIS.

Authors:  W A SIBLEY; J M FOLEY
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Familial and conjugal multiple sclerosis.

Authors:  K SCHAPIRA; D C POSKANZER; H MILLER
Journal:  Brain       Date:  1963-06       Impact factor: 13.501

3.  [Genesis of acute demyelinating encephalitis].

Authors:  F SEITELBERGER; K JELLINGER; H TSCHABITSCHER
Journal:  Wien Klin Wochenschr       Date:  1958-06-20       Impact factor: 1.704

4.  The association of cervical spondylosis and disseminated sclerosis.

Authors:  R BRAIN; M WILKINSON
Journal:  Brain       Date:  1957-12       Impact factor: 13.501

5.  [Neuropathologic study of case of multiple sclerosis. Discussion of the viral nature of particles observed by electron microscope in a cerebral biopsy and in cell cultures].

Authors:  F Lhermitte; R Escourolle; F Cathala; J J Hauw; R Marteau
Journal:  Rev Neurol (Paris)       Date:  1973-07       Impact factor: 2.607

6.  [Permeability of the cerebral vessels. VI. Experimental demyelination produced by substances acting on the hemato-encephalic barrier].

Authors:  R Gonsette; G Andre-Balisaux; P Delmotte
Journal:  Acta Neurol Psychiatr Belg       Date:  1966-04

7.  Declining incidence of multiple sclerosis in the Orkney Islands.

Authors:  S D Cook; J I Cromarty; W Tapp; D Poskanzer; J D Walker; P C Dowling
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

8.  Pathologic-anatomical findings and cerebral localization in stereotactic treatment of extrapyramidal motor disturbances in multiple sclerosis.

Authors:  T Riechert; R Hassler; F Mundinger; F Bronisch; K Schmidt
Journal:  Confin Neurol       Date:  1975

9.  Pathophysiology of vascular consequences of experimental concussive brain injury.

Authors:  H A Kontos; E P Wei; J T Povlishock
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

10.  Magnetic resonance imaging and other techniques in the diagnosis of multiple sclerosis.

Authors:  H S Kirshner; S I Tsai; V M Runge; A C Price
Journal:  Arch Neurol       Date:  1985-09
View more
  12 in total

1.  The relevance of animal models in multiple sclerosis research.

Authors:  Aleksandar Denic; Aaron J Johnson; Allan J Bieber; Arthur E Warrington; Moses Rodriguez; Istvan Pirko
Journal:  Pathophysiology       Date:  2011-02

2.  Acute monophasic focal demyelinating diseases of the central nervous system: longitudinal clinico-neuroradiological study of two patients.

Authors:  P Di Bella; F Logullo; M Danni; F Angeleri; L Chiaramoni; M Maricotti; N Foschi; U Salvolini
Journal:  Ital J Neurol Sci       Date:  1992-12

3.  An association between multiple sclerosis and diabetes mellitus.

Authors:  Y De Smet; J M Brucher
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

4.  Trauma and multiple sclerosis. An hypothesis.

Authors:  C M Poser
Journal:  J Neurol       Date:  1987-04       Impact factor: 4.849

5.  Kallikrein 6 regulates early CNS demyelination in a viral model of multiple sclerosis.

Authors:  Isobel A Scarisbrick; Hyesook Yoon; Michael Panos; Nadya Larson; Sachiko I Blaber; Michael Blaber; Moses Rodriguez
Journal:  Brain Pathol       Date:  2012-03-21       Impact factor: 6.508

6.  Virus-mediated autoimmunity in Multiple Sclerosis.

Authors:  Nikolaos Grigoriadis; Georgios M Hadjigeorgiou
Journal:  J Autoimmune Dis       Date:  2006-02-19

Review 7.  Animal models of Multiple Sclerosis.

Authors:  Claudio Procaccini; Veronica De Rosa; Valentina Pucino; Luigi Formisano; Giuseppe Matarese
Journal:  Eur J Pharmacol       Date:  2015-03-27       Impact factor: 4.432

8.  Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.

Authors:  S P Cramer; H Simonsen; J L Frederiksen; E Rostrup; H B W Larsson
Journal:  Neuroimage Clin       Date:  2013-12-10       Impact factor: 4.881

9.  Rapid isolation of morbillivirus nucleocapsid for genomic RNA cDNA cloning and the production of specific core protein antisera.

Authors:  M Oglesbee; L Tatalick; S Ringler; J Rice; S Krakowka
Journal:  J Virol Methods       Date:  1989-06       Impact factor: 2.014

Review 10.  The pathogenesis of multiple sclerosis. Additional considerations.

Authors:  C M Poser
Journal:  J Neurol Sci       Date:  1993-04       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.